PACE, FABIO
 Distribuzione geografica
Continente #
EU - Europa 10.636
NA - Nord America 5.657
AS - Asia 5.096
SA - Sud America 522
AF - Africa 141
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.073
Nazione #
US - Stati Uniti d'America 5.538
IT - Italia 3.737
GB - Regno Unito 3.003
SG - Singapore 1.568
CN - Cina 1.540
SE - Svezia 821
RU - Federazione Russa 581
DE - Germania 548
UA - Ucraina 429
FR - Francia 428
HK - Hong Kong 426
NL - Olanda 390
TR - Turchia 338
BR - Brasile 337
VN - Vietnam 297
KR - Corea 274
IN - India 254
IE - Irlanda 199
EU - Europa 140
FI - Finlandia 139
CO - Colombia 122
BD - Bangladesh 86
PL - Polonia 77
CA - Canada 69
GR - Grecia 64
JP - Giappone 57
CI - Costa d'Avorio 52
CH - Svizzera 49
DK - Danimarca 48
ID - Indonesia 39
BE - Belgio 36
AR - Argentina 29
IQ - Iraq 26
MX - Messico 25
UZ - Uzbekistan 22
PK - Pakistan 21
SA - Arabia Saudita 19
PH - Filippine 17
AU - Australia 15
ZA - Sudafrica 15
EG - Egitto 13
ES - Italia 13
TH - Thailandia 12
RO - Romania 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
MY - Malesia 10
PT - Portogallo 9
TN - Tunisia 9
MA - Marocco 8
TW - Taiwan 8
AT - Austria 7
AZ - Azerbaigian 7
ET - Etiopia 7
IL - Israele 7
KE - Kenya 7
EC - Ecuador 6
IR - Iran 6
CL - Cile 5
DZ - Algeria 5
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
NP - Nepal 5
OM - Oman 5
PY - Paraguay 5
SN - Senegal 5
VE - Venezuela 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CR - Costa Rica 4
HR - Croazia 4
PE - Perù 4
QA - Qatar 4
SM - San Marino 4
TT - Trinidad e Tobago 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GH - Ghana 3
GT - Guatemala 3
KH - Cambogia 3
MD - Moldavia 3
MU - Mauritius 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BF - Burkina Faso 2
BG - Bulgaria 2
BY - Bielorussia 2
DM - Dominica 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MM - Myanmar 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
TD - Ciad 2
UY - Uruguay 2
Totale 22.176
Città #
Southend 2.811
Singapore 921
Chandler 535
Ashburn 463
Milan 415
Hong Kong 405
Beijing 399
Jacksonville 367
Seattle 357
Rome 272
Princeton 269
San Jose 267
Dallas 232
Dublin 198
Wilmington 174
Bengaluru 167
Somerville 159
Redmond 151
Council Bluffs 148
Los Angeles 144
Mountain View 134
Ann Arbor 120
Serra 118
Sakarya 114
Bogotá 113
Nanjing 113
Boardman 112
Santa Clara 110
Andover 109
Lauterbourg 104
Des Moines 94
Moscow 82
Buffalo 81
Hanoi 79
Ho Chi Minh City 73
Warsaw 66
Woodbridge 65
Shanghai 62
Dearborn 59
Guangzhou 58
Frankfurt am Main 56
Naples 55
Bologna 53
Abidjan 52
Verona 51
New York 49
Tokyo 49
Cangzhou 42
Shenyang 41
Athens 39
Columbus 39
Roxbury 39
Tianjin 38
Turin 37
Westminster 36
Toronto 33
Hefei 32
Brescia 31
Hangzhou 31
Nanchang 31
Berlin 30
Houston 30
The Dalles 30
Fairfield 27
Munich 27
Bitonto 24
Grafing 24
Jinan 24
Chicago 23
Bari 22
Hebei 22
Padova 22
Cagliari 21
Fuzhou 21
Istanbul 21
Jiaxing 21
Redwood City 21
São Paulo 21
Changsha 20
Bergamo 19
Mumbai 19
Seoul 19
Torino 19
Medford 18
Florence 17
Kunming 17
Napoli 17
Pisa 17
San Diego 17
Shenzhen 17
Brussels 16
Catania 16
Monza 16
Norwalk 16
Phoenix 16
Taranto 16
Genoa 15
Helsinki 15
Palermo 15
Saint Petersburg 15
Totale 12.357
Nome #
Acantosi glicogenica 2.381
Strumenti per la valutazione della malattia da reflusso gastro-esofageo (MRGE). La scala GIS (GERD Impact Scale) 1.024
Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux disease 511
Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S) 296
Assessment of gastro-oesophageal reflux symptoms in Italian physicians - A survey by Reflux Disease Questionnaire 268
Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia 240
Visceral hypersensitivity is not a feature of fibromyalgia syndrome 240
An uncommon cause of corrosive esophageal injury 230
A review of rabeprazole in the treatment of acid-related diseases 225
Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain 220
Utilisation d'index de qualité pour la prise en charge du reflux gastro-oesophagien et l'évaluation des effets thérapeutiques = The use of quality of life tools in the management of patients with gastroesophageal reflux disease 216
Barrett's esophagus: proton pump inhibitors and chemoprevention II 210
Inflammatory bowel disease versus irritable bowel syndrome : a hospital-based, case-control study of disease impact on quality of life 206
Usefulness of PH-impedance monitoring (PH-MII) in a tertiary referral centre 206
Argomenti di patologia esofagea 203
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 201
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease : a randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 200
Terapia endoscopica nella malattia da reflusso gastroesofageo 199
Artificial neural networks are able to recognize gastro-oesophageal reflux patients solely on the basis of clinical data 198
The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms 197
Gut microbiota, dysbiosis and colon lavage 194
Systematic review: gastro-oesophageal reflux disease and dental lesions 193
IBS in tertiary care after a 4 years follow-up: outcome and relevance of rectal perception testing 193
Review article: endoscopic antireflux procedures : an unfulfilled promise? 192
Storia naturale della malattia da reflusso gastroesofageo senza esofagite (NERD): rivalutazione a 10 anni di distanza 192
Appropriateness of upper GI endoscopy in patients with GERD: results of a 2-week multicentre survey 192
Heterogeneity of endoscopy negative heartburn : epidemiology and natural history 192
GERD symptoms in obstructive sleep apnoea patients 192
La manometria-impedenziometria esofagea = The esophageal-manometry impedance 190
Common pathogenetic mechanisms of functional syndromes 188
Autonomic nervous system dysregulation in irritable bowel syndrome 188
Persisting changes of intestinal microbiota after bowel lavage and colonoscopy 188
A phase III, 6-month, double-blind, placebo-controlled, randomized withdrawal trial of the selective CCK-1 antagonist dexloxiglumide in constipation-predominant IBS: the Darwin Study 187
Natural history of NERD in 3 italian tertiary referral centres after 5 years of follow-up 187
Non-acid reflux and biliary reflux : a comparison between 24-H intraluminal impedance and bilitec monitoring of the oesophagus 187
Epidemiological aspects of irritable bowel syndrome in Europe and North America 185
Diagnostic yield of PH-impedance monitoring (PH-MII) in a tertiary referral centre : the experience of the first four years 183
Disturbi motori 183
Chronic diarrhoea and gastroesophageal reflux disease 182
The role of multichannel intraluminal impedance (MII) in selecting candidates for Laparoscopic Nissen Fundoplication (LFN) 181
GERD symptoms and quality of life in obstructive sleep apnoea patients 181
Usefulness of PH-impedance monitoring (PH-MII) in a tertiary referral centre 178
Argomenti di patologia esofagea 176
Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation 176
Bilateral pneumothorax and pneumomediastinum during upper endoscopy: the role of gastric perforation and of cardiopulmonary resuscitation maneuvres 175
Tomografia a coerenza ottica : esame istologico non invasivo dell'apparato digerente 175
Determinants of proximal esophageal reflux extension at intraluminal impedance monitoring (IIM) assessed by artificial neural networks (ANNS) 174
IBS in tertiary care after a 4 years follow-up : outcome and relevance of rectal perception testing 174
On-demand PPI therapy in GERD 173
Increased cardiac vagal modulation in patients with reflux esophagitis 173
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease 172
Immunogenicity and autoimmunity during anti-TNF therapy 171
Gastroesophageal reflux disease is a progressive disease 170
Membro del Comitato scientifico di Giornale italiano di health technology assessment 169
The role of Multichannel Intraluminal Impedence (MII) in selecting candidates for Laparoscopic Nissen Fundoplication (LFN) 169
Argomenti di Patologia Esofagea 168
L'impedenziometria esofagea multicanale 168
Argomenti di patologia esofagea 167
Co-morbidità funzionale digestiva in pazienti con disturbi psichiatrici 167
NERD in tertiary care : management strategies and outcome after a 5-year follow-up 166
Qualità di vita nelle malattie gastroenterologiche 165
ANNs in the recognition of refluxer and non refluxer GERD patients only on the basis of clinical data 165
Studi funzionali 163
Natural history of gastroesophageal reflux disease without esophagitis (NERD) - A reappraisal 10 years after 162
Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring 161
Terapia attuale e opzioni future per il reflusso gastroesofageo 161
Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand' 159
La terapia medica del reflusso gastroesofageo 158
Natural history of gastroesophageal reflux disease without esophagitis (NERD) - A reappraisal 10 years after 158
Data mining of GERD symptoms through a novel adapting auto-CM mapping method 156
Rabeprazole is more rapid than omeprazole in relieving reflux symptoms in oesophagitis patients 155
What is new in esophageal injury (infection,drug-induced, caustic, stricture, perforation)? 153
Nongastroesophageal reflux disease-related infectious, inflammatory and injurious disorders of the esophagus 152
Storia naturale della MRGE 152
Fisiopatologia del reflusso gastroesofageo 151
Psychological features of patients with Crohn's disease (CD) and irritable bowel syndrome (IBS). A hospital-based study 151
Reflusso gastroesofageo. Fisiopatologia, clinica e terapia 150
Italian consensus conference for colonic diverticulosis and diverticular disease 150
Gastroesophageal reflux disease : a typical spectrum disease (a new conceptual framework is not needed) 149
"True" non erosive reflux disease (NERD) is characterized by a lower response to proton-pump inhibitors (PPIS)compared to erosive reflux disease (ERD) 149
Pathogenesis of GERD, and its worldwide implications 148
Rabeprazole : a second-generation proton pump inhibitor in the treatment of acid-related disease 148
Qualità percepita ed efficacia della didattica frontale in medicina interna : risultati preliminari e proposta di modello valutativo 146
Non acid bolus exposure and biliary reflux : a comparison between esophageal 24-H multichannel intraluminal impedance (miiR)and Bilitec 146
Endoscopic treatment of GERD 145
Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)- a reappraisal 10 years on 145
Utilizzo delle reti neurali nella diagnosi di MRGE 143
Rabeprazole is more rapid than omeprazole in providing symptoms relief in oesophagitis patients 143
Use of artificial neural networks in predicting diagnosis in patients with gastroesophageal reflux disease 143
Outcome research in gastroenterology : The case of gastroesophageal reflux disease (GERD) 141
Long-term, low-dose treatment with rabeprazole is effective in preventing relapse of reflux oesophagitis 141
Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin 141
Fisiopatologia della MRGE nel paziente con IMC elevato 139
Innovations in oesophageal function testing 138
24-hour ambulatory intraluminal pH-impedance in patients with non erosive reflux disease (NERD) 135
Increased cardiac vagal modulation in patients with gastroesophageal reflux disease 135
Role of alimentation in irritable bowel syndrome 134
The rectum : a window to irritable bowel syndrome? 134
Qualità di vita e impatto clinico della malattia da reflusso gastroesofageo 133
Technologies in the evaluation of irritable bowel syndrome 131
Totale 20.811
Categoria #
all - tutte 51.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/20221.256 84 29 30 98 26 64 153 110 75 187 91 309
2022/20232.090 206 191 138 318 261 365 102 111 219 42 70 67
2023/20241.240 53 116 63 78 241 71 98 76 38 89 137 180
2024/20252.939 135 232 99 291 247 117 104 312 168 320 272 642
2025/20264.835 553 387 450 408 494 370 482 349 559 500 217 66
Totale 23.117